Combining radiation and chemo to make colon cancer removable
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether giving radiation therapy along with standard chemotherapy before surgery can help shrink advanced colon cancer that has grown through the bowel wall but hasn't spread to other organs. It is for a specific type of colon cancer called pMMR/MSS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- Your colon cancer has grown through the bowel wall but hasn't spread to other organs (stage T4NanyM0).
- Your cancer type is pMMR/MSS (a specific genetic type).
- You are well enough to be up and about (ECOG 0 or 1).
- Your blood counts, liver, and kidney function are within acceptable ranges.
- You have not had previous treatment like chemo, radiation, or targeted therapy for this cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving chemotherapy followed by an immunotherapy drug (a checkpoint inhibitor) before surgery helps shrink locally advanced colon cancer. It is for people with a specific tumor type (MSS and RAS mutation) who have not had prior treatment.
This trial tests whether giving chemotherapy before surgery can improve outcomes for people with colon cancer that has grown into nearby tissue or lymph nodes but hasn't spread to other organs. It is for patients whose tumors are mismatch repair proficient (pMMR) or microsatellite stable (MSS).
This trial tests whether adding a new immunotherapy drug (ivonescimab) to standard chemotherapy (CAPOX) before surgery can improve outcomes for people with locally advanced colon cancer. It compares the combination to chemotherapy alone.
This trial tests a combination of short-course radiation, chemotherapy (CAPOX), and an immunotherapy drug (sintilimab) before surgery for people with locally advanced colon cancer that is not the highly unstable type. The goal is to see if this approach can safely spare more of the lymph nodes while still treating the cancer effectively.
This trial tests whether adding a very low dose of radiation to a combination of immunotherapy (pucotenlimab) and chemotherapy (CAPEOX) can help shrink rectal cancer tumors that have not spread. It is for people with locally advanced rectal cancer that is pMMR (meaning the cancer cells have normal DNA repair).
This trial is testing a combination of chemotherapy and targeted therapy with or without adding radiation and two immunotherapy drugs for advanced rectal cancer that has spread. It looks at whether adding radiation and immunotherapy can help control the cancer better for people with certain genetic types (RAS mutation and pMMR).
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.